Regional clinical trials

Explore recruiting regional clinical trials.

Recruiting regional studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Regional trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Characterization of cerebral tau aggregates with 18F-RO6958948 PET in the ALFA population

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II Randomized Controlled Trial of Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab in Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

EORTC 1740: Randomized Phase II study of Cisplatin plus Radiotherapy versus Durvalumab plus Radiotherapy followed by Adjuvant Durvalumab versus Durvalumab plus Radiotherapy followed by Adjuvant Tremelimumab Durvalumab in Intermediate Risk HPV-Positive Locoregionally Advanced Oropharyngeal Squamous Cell Cancer (LA-OSCC)

Belgium, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Tau and Amyloid PET imaging in normal aging, early Alzheimer's disease and related syndroms.

Belgium

Phase II and Phase III (Integrated) EU CTIS Study details

Phase IIb, randomised, controlled, unblinded, multicentre, clinical trial to evaluate the clinical efficacy of a nanostructured fibrin-agarose artificial cornea model (NANOULCOR) in patients with severe corneal ulcers.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Comparison of PENG block and lumbar plexus block in terms of postoperative analgesia and mobilization for fast track primary hip arthroplasty

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Regional trials by city

Regional in Toronto Regional in Vancouver Regional in Montreal Regional in Calgary Regional in Edmonton Regional in Ottawa Regional in Winnipeg Regional in Quebec City Regional in Hamilton Regional in Kitchener Regional in London Regional in Halifax Regional in New York Regional in Los Angeles Regional in Chicago Regional in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease